Can we identify novel angiogenesis inhibitors from cultured embryonic cells?

Medical Hypotheses

Volumn 60, Issue 3, 2003, Pages 389-390

  Yamagishi, Sho Ichi ^a   Okamoto, T ^a   Amano, S ^a   Inagaki, Y ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DNA; VASCULOTROPIN;

ANGIOGENESIS; CELL CULTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA MICROARRAY; DNA SYNTHESIS; EMBRYO; EMBRYO CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; SHORT SURVEY; TUMOR GROWTH;

EID: 0037369344     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00408-5     Document Type: Short Survey

References (11)

1. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature 1980; 288: 551-556.
2. Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
3. D'Amore P. A., Thompson R. W. Mechanism of angiogenesis. Annu Rev Physiol 1987; 49: 453-464.
4. Sato Y., Rifkin D. B. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107: 1199-1205.
5. Yamagishi S., Yonekura H., Yamamoto Y. et al. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 1997; 272: 8723-8730.
6. Segawa Y., Shirao Y., Yamagishi S. et al. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. Ophthalmic Res 1998; 30: 333-339.
7. Yamagishi S., Kawakami T., Fujimori H. et al. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc Res 1999; 57: 329-339.
8. Tsuchida K., Makita Z., Yamagishi S. et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 1999; 42: 579-588.
9. Alton T., Hemo I., Itin A., Peer J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1: 1024-1028.
10. Maione I. E. G. S., Gray J., Petro A. J. et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990; 247: 77-79.
11. Breier G., Damert A., Plate K. H., Risau W. Angiogenesis in embryos and ischemic diseases. Thromb Haemost 1997; 78: 678-683.